Label Image (Lyrica 50 mg)
Lyrica
Product Images NDC 16590-503
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lyrica (NDC 16590-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure Of The Cockcroft And Gault Equation (Lyrica 1)
Figure 8: Patients Achieving Various Levels Of Pain Relief – Fibromyalgia Study F1 (Lyrica 10)
Figure 9: Time To Loss Of Therapeutic Response, Fibromyalgia Study F2 (kaplan-meier Analysis) (Lyrica 11)
The Chemical Structure Of Pregabalin. (Lyrica 2)
Figure 1: Patients Achieving Various Levels Of Pain Relief – Study Dpn 1 (Lyrica 3)
Figure 2: Patients Achieving Various Levels Of Pain Relief – Study Dpn 2 (Lyrica 4)
Figure 3: Patients Achieving Various Levels Of Pain Relief – Study Phn 1 (Lyrica 5)
Figure 4: Patients Achieving Various Levels Of Pain Relief – Study Phn 2 (Lyrica 6)
Figure 5: Patients Achieving Various Levels Of Pain Relief – Study Phn 3 (Lyrica 7)
The text is showing the percent improvement in pain from baseline for two types of medications - Pregatalin and Pregabalin, taken three times a day. The name "Placata" is also mentioned but it is not clear what it refers to.*
Figure 6. Responder Rate By Add-on Epilepsy Study (Lyrica 8)
Figure 7. Seizure Reduction By Dose (all Partial Onset Seizures) For Studies E1, E2, And E3 (Lyrica 9)
This is not a readable text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
